Skip to main content
. 2021 Sep 2;61(1):447–459. doi: 10.1007/s00394-021-02656-3

Table 4.

Effect of vitamin C supplementation on subjective vitality

Vitamin C (n = 24) Placebo (n = 22) Vitamin C vs. placebo
Baseline Endpoint Changea Baseline Endpoint Change Difference in change (95% CI) Pb
Fatigue 9.3 ± 2.4 7.8 ± 2.7 − 1.5 ± 2.5** 8.9 ± 2.1 8.9 ± 1.9 − 0.05 ± 2.6 − 1.5 (− 3.0, 0.1) 0.06
Attention 7.1 ± 1.8 9.0 ± 2.4 1.9 ± 2.7** 7.7 ± 2.1 8.0 ± 2.0 0.3 ± 2.5 1.6 (0.1, 3.2) 0.03
Work engagement 68.7 ± 14.9 74.4 ± 16.1 5.8 ± 10.2* 74.3 ± 13.9 74.7 ± 14.1 0.4 ± 9.7 5.3 (− 0.6, 11.3) 0.07
Vigor 23.2 ± 5.7 25.8 ± 6.0 2.5 ± 4.2** 25.4 ± 5.4 27.0 ± 5.7 1.5 ± 4.0 1.0 (− 1.4, 3.4) 0.41
Dedication 23.0 ± 6.8 24.1 ± 6.6 1.0 ± 4.0 24.5 ± 5.3 23.9 ± 5.4 − 0.6 ± 4.1 1.7 (− 0.7, 4.1) 0.16
Absorption 22.4 ± 4.9 24.6 ± 5.5 2.2 ± 4.0* 24.3 ± 5.1 23.8 ± 5.9 − 0.5 ± 4.1 2.7 (0.3, 5.1) 0.03
Self-control resources 16.5 ± 4.3 18.5 ± 5.3 2.0 ± 4.7* 16.1 ± 4.1 17.5 ± 4.4 1.4 ± 4.8 0.5 (− 2.3, 3.3) 0.72

Values are presented as mean ± SD

There were no significant differences between the vitamin C group and the placebo group for all variables measured at the baseline (all p > 0.05; unpaired t test)

aBaseline and endpoint (week 4) measures differed significantly within the vitamin C group (*p < 0.05, **p < 0.01; paired t test)

bA repeated-measures ANOVA with Bonferroni correction was used to determine the time-by-group interaction with time as the within-subject factor and treatment (vitamin C versus placebo) as the between-subject factor